Swiss Nordic Bio 2026

1 Oct 2026 | Zürich, Switzerland

Register
Register
Register

Kerna Ventures

Investor

kerna.vc/London, United Kingdom
2 profile visits

About

Early-stage (pre-seed to series B) therapeutics-focused investor based in London, San Francisco, and Abu Dhabi.

Areas of Activity

Biotech / PharmaBroad Scope Investments

We are looking for

Venture capital

Therapeutic areas

Cardiology/Vascular DiseasesDental & Oral HealthDermatologyEndocrinologyGastroenterologyGenetic DiseaseHematologyHepatologyImmunologyInternal MedicineMusculoskeletalNephrologyNeurologyNutrition & Weight LossObstetrics/GynecologyOncologyOphthalmologyOrthopedics/Orthopedic SurgeryOtolaryngologyPediatrics/NeonatologyPharmacology/ToxicologyPodiatryPsychiatry/PsychologyPulmonary/Respiratory DiseasesRare DiseaseRheumatologyTraumaUrologyVaccines

Phase of our company

Preclinical research

Representatives

Lead Investor

Kerna Ventures